"AdventHealth Medical Group is a coalition of nearly 2,000 physicians, residents, fellows and faculty members. This comprehensive network spans 9 states - offering you an unparalleled continuum of care across the country. From primary care doctors to pediatricians and surgical specialists, we have physicians for every age and every stage of life. From the Rocky Mountains to the Florida Coast, AdventHealth Medical Group offers you consistent, collaborative and compassionate health care."

During the past decade, Advent Health Medical Group Blood & Marrow Transplant conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advent Health Medical Group Blood & Marrow Transplant" #1 sponsor was "NexImmune Inc." with 2 trials, followed by "Incyte Corporation" with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored, "Juno Therapeutics, a Subsidiary of Celgene" with 1 trials sponsored and "Sumitomo Pharma Oncology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advent Health Medical Group Blood & Marrow Transplant" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Advent Health Medical Group Blood & Marrow Transplant" are "Acute Myeloid Leukemia (AML)" (2 trials), "Acute-graft-versus-host Disease" (1 trials), "Graft-versus-host Disease" (1 trials), "Graft-versus-host Disease (GVHD)" (1 trials) and "Immune System Disorder" (1 trials). Many other conditions were trialed in "Advent Health Medical Group Blood & Marrow Transplant" in a lesser frequency.

Most popular intervention types in "Advent Health Medical Group Blood & Marrow Transplant" are "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Alvocidib (flavopiridol)" (1 trials), "Alvocidib (flavopiridol) and cytarabine (Ara-C)" (1 trials), "Defibrotide" (1 trials), "Infusion of NEXI-001 T Cells" (1 trials) and "NEXI-002 T Cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advent Health Medical Group Blood & Marrow Transplant" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Advent Health Medical Group Blood & Marrow Transplant". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Advent Health Medical Group Blood & Marrow Transplant, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advent Health Medical Group Blood & Marrow Transplant, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".